NCT00975754 - Lung Deposition Via Different Inhalation Devices | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Study Completion Date

November 30, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

Pulmicort pMDI HFA

Inhalation aerosol, 200 μg/ metered dose. Each subject receive a single dose from 4 inhalations

DRUG

Budesonide pMDI HFA

Inhalation aerosol, 160 μg/ metered dose. Each subject receive a single dose from 4 inhalations

DRUG

Pulmicort Repulses

Suspension for nebulisation, 0.5 mg/mL. Each subject receive a single dose from 100 inhalations

DRUG

Pulmicort Turbohaler

Inhaled powder, 200 μg/ metered dose. Each subject receive a single dose from 4 inhalations

Trial Locations (1)

Research Site, Lund